◆ 会议时间：2022年3月30日至4月2日
◆ 会议地点：线上会议（online）

◆ 会议简介：

2022年欧洲肺癌大会(ELCC2022)将于2022年3月30日至4月2日以线上虚拟会议形式举行，会议由欧洲肿瘤内科学会（ESMO）与国际肺癌研究协会（IASLC）联合组织。ELCC由代表胸部肿瘤专家的最重要的多学科学会联合协作举办，以促进科学发展、传播教育和提高全世界肺癌专家的实践。领域国际医学会议网；回顾当前肺癌治疗的最新技术，更新您在预防、筛查、检测等方面的知识，与会者将从其全面而令人振奋的科学计划宣中受益。自2008年首次举办以来，ELCC已成为该领域专业人士的首要会议，大会与会者包括肿瘤内科医师、放射肿瘤学家、胸外科医生、呼吸内科医师/肺科医师、介入放射科医师、病理学家等众多专家学者。2022年欧洲肺癌大会(ELCC2022)预计有超过2000名专业人士与会。

国际肺癌研究协会（IASLC）成立于1974年，是全球唯一致力于肺癌研究的组织，由致力于肺癌领域研究的专家们发起和创立,成员包括来自于全球100多个国家的5000多名肺癌专家。IASLC在肺癌和其他胸部恶性肿瘤的病因学、流行病学、预防、诊断、治疗以及与之相关的领域开展深入研究，为医学团体与大众服务。

欧洲肿瘤内科学会（ESMO）成立于1975年，是欧洲领先的肿瘤内科学专业组织，现在全球150多个国家和地区拥有超过17,000名会员，是肿瘤学教育和信息的参考学会，ESMO致力于支持其会员在快速发展的专业环境中得到发展与进步。作为一个非营利组织，ESMO一直以推动癌症护理和治疗为使命，致力于推进肿瘤医学专业的发展，以多学科的方法来促进癌症的治疗和护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

European Lung Cancer Congress (ELCC 2022)
Date: 30 March – 2 April 2022
Venue: Virtual(虚拟会议)

The European Lung Cancer Congress (ELCC 2022), will be a hybrid meeting, taking place onsite in Prague, Czech Republic, from 30 March-2 April 2022, and online, through a virtual platform.

The European Lung Cancer Congress (ELCC 2022) is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.

Review the current state-of-the-art in lung cancer therapy, update your knowledge in prevention, screening, detection and much more. Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists all benefit from its comprehensive and stimulating programme.

Make sure you connect to this highly interactive meeting and share your expertise with lung cancer specialists from all over the world. Thanks to its innovative format, ELCC 2022 is easily accessible to a global audience.

摘要征集：

Abstract submission deadlines

点此提交摘要>>>Submit Abstract>>>

摘要提交指南>>>Abstract regulations>>>

Submission categories

• Tumour biology and pathology
• Translational research
• Prevention, early detection, epidemiology, tobacco control
• Imaging and staging
• SCLC
• Early stage NSCLC
• Locally advanced NSCLC
• Advanced NSCLC
• Metastases to and from the lung
• Mesothelioma
• General interest

Late-breaking abstracts (LBA)

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.  

Only abstracts for which no conclusive data are available at the time of the abstract submission deadline of 17 January 2021 will be considered for late-breaking status. The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to the ELCC 2022.

A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on of Monday, 17 January 2022.   

Submitters of preliminary versions receiving approval to proceed must submit the final LBA by Tuesday, 01 March 2022. 

Trial in progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ELCC 2022

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

• Background
• Trial design

Notes:

• Recruitment must have already begun or have been completed by the abstract submission deadline of 17 January 2022.
• Abstracts including results or preliminary data will be rejected.
• Trial in Progress abstracts will not be considered for Proffered Paper (oral) presentation or Mini Oral.
• Encore TiP abstracts will NOT be accepted.

Presentation options for accepted abstracts 

The ELCC 2022 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
• Mini Oral – Short oral presentation by authors with comment and interactive audience discussion led by an invited expert.
• Poster – Display session for review, discussion and questions.

All accepted abstracts will be published in the ELCC 2022 Abstract book, a supplement to the official ESMO journal, Annals of Oncology.

Travel Grants

A limited number of Travel Grants are available, upon application, to first authors under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by ELCC 2022 Scientific Committee on a competitive basis from among the accepted abstracts.

ELCC 2022 注册费：

Registration fees and deadlines 

Individual registration will remain open for the duration of the Congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines. 

Webcasts

The Congress webcasts will be available for all delegates and will include all the sessions of the official programme where speaker permission is granted. ESMO Members who do not register for the Congress will have access to the resources 2 months after the end of the meeting.

注册费包括：

In-person participation includes:

• Participation in the scientific and educational live sessions with the possibility to interact with the expert panel table
• Onsite networking opportunity with faculty and peers
• Entry to the Poster and e-Poster area
• Interaction with the industry partners in the trade exhibition
• Participation in the Industry Satellite Symposia participation
• Access to the Virtual Platform to view the missed sessions on-demand
• Post-event resources
• Coffee breaks

Online participation includes:

• Access to the virtual platform, with live streaming of all sessions
• Possibility to interact through the chat live discussion
• Entry to the virtual exhibition
• Participation in the Industry Satellite Symposia
• Post-event resources on OncologyPRO

退款政策
Refund policy

Registration refunds will be granted if notification of cancellation is sent in writing to the ESMO Congress Secretariat before 16 February 2022. After this date, refunds will not be possible. Refunds by bank transfer or to a credit card will be processed after the Congress.

◆ 参会对象：肿瘤科医师、放射（肿瘤）科医师，胸外科医师，呼吸内科医师，介入放射科医师，病理科医师，护士以及从事肿瘤护理与研究的其他相关专业人士等。